Pfizer invites organizations to apply for grants to support independent medical education initiatives aimed at improving the medical and scientific understanding of emerging treatment options for patients with Hemophilia.
Category
Grant
Area of Interest
Eligible projects should focus on:
- Educating on the evolving treatment landscape for hemophilia, including genetic medicine and rebalancing strategies, to improve understanding and clinical applicability.
- Discussing shared decision making (SDM) and practical approaches to incorporating SDM into hemophilia patient care.
- Educating on the benefits of omnichannel healthcare strategies for seamless, personalized patient care.
- Sharing knowledge and best practices on preparing for novel therapies in Hemophilia Treatment Centers (HTCs) and multidisciplinary teams.
- Advancing patient education on the evolving hemophilia treatment landscape to improve patient empowerment and decision-making.
Funding Information
Individual projects requesting up to $100,000 will be considered.
Target Audience
Members of multidisciplinary teams caring for Hemophilia patients, including but not limited to Hematologists, Pharmacists, Specialty Nurses, Genetic Counsellors, Medical Geneticists, and other Physicians.
Geographic Focus
Global (excluding United States)
Eligibility Criteria
Eligible applicants include:
- Medical, dental, nursing, allied health, and/or pharmacy professional schools
- Healthcare institutions (both large and small)
- Professional associations and medical societies
- Patient advocacy groups
- Medical education companies
- Other entities with a mission related to healthcare professional education and/or improvement
For projects involving multiple departments or institutions, all must have a relevant role, and the requesting organization must play a key role. For projects offering continuing education credit, the requesting organization must be accredited.
0 Comments